The Nature and Treatment of Anxiety Disorders |
From inside the book
Results 1-3 of 43
Page 161
... initial stages of treatment . While many patients are able to make use of logical challenges to their beliefs , others seem outright skeptical regarding the value of such procedures or seem to produce " coping thoughts " or other ...
... initial stages of treatment . While many patients are able to make use of logical challenges to their beliefs , others seem outright skeptical regarding the value of such procedures or seem to produce " coping thoughts " or other ...
Page 286
... initial dose , and dose range of the available ben- zodiazepines can be seen in Table 11.1 TABLE 11.1 Benzodiazepines Generic Representative Initial Usual Brand Oral Dose Dose ( mg ) Range ( mg / day ) Longer Half - Life ...
... initial dose , and dose range of the available ben- zodiazepines can be seen in Table 11.1 TABLE 11.1 Benzodiazepines Generic Representative Initial Usual Brand Oral Dose Dose ( mg ) Range ( mg / day ) Longer Half - Life ...
Page 292
... initial and usual dose ranges . TABLE 11.2 Antidepressants Generic Representative Brand Initial Usual Oral Dose Dose ( mg ) Range ( mg / day ) Tricyclics Amitriptyline Elavil , Endep 25-50 50-300 Desipramine Norpramin , Pertofane 25-50 ...
... initial and usual dose ranges . TABLE 11.2 Antidepressants Generic Representative Brand Initial Usual Oral Dose Dose ( mg ) Range ( mg / day ) Tricyclics Amitriptyline Elavil , Endep 25-50 50-300 Desipramine Norpramin , Pertofane 25-50 ...
Contents
Theories of Anxiety | 15 |
Anxiety Syndromes and Disorders | 43 |
An Overview of Symptom | 69 |
Copyright | |
14 other sections not shown
Other editions - View all
Common terms and phrases
activity acute agoraphobia agoraphobic agoraphobic patients alcohol alprazolam antidepressants anxiety disorders anxiolytic anxious patients arousal assessment associated avoidance behavior therapy Behaviour Research benzodiazepines buspirone BZDs cause changes chapter clinical cognitive therapy common coping criteria depression developed diagnosis diazepam discussed dose drive drugs DSM-III-R evaluation experience experienced exposure therapy factors feeling frequently function heart rate hyperventilation iety imipramine important increased intensity intervention involved Journal of Psychiatry Joyce lactate locus coeruleus lorazepam MAOI measures medication ment months muscle occur onset panic attacks panic disorder panic disorder patients patients with panic percent person phenelzine physiologic practice present problems procedure propanolol Psychiatry psychodynamic psychological psychotherapy reduce relaxation reported Research and Therapy response self-efficacy self-statements sensations session side effects simple phobias social phobia somatic specific stimuli stress studies symp syndrome tasks TCAs theory therapeutic therapist thoughts tients tion treat treatment vivo exposure walk weeks withdrawal worry